
Zhejiang Hisun Pharmaceutical Co., Ltd.
SSE:600267.SS
9.42 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 9,786.848 | 10,373.072 | 12,036.69 | 12,136.466 | 11,354.396 | 11,071.784 | 10,187.441 | 10,571.527 | 9,733.423 | 8,767.428 | 10,096.748 | 8,604.312 | 5,801.766 | 5,161.394 | 4,544.509 | 4,003.47 | 3,181.978 | 2,838.771 | 2,261.986 | 1,905.87 | 1,779.836 | 1,550.954 | 762.317 | 575.832 | 518.004 | 357.911 | 283.657 | 269.558 |
Cost of Revenue
| 5,407.122 | 6,188.821 | 6,998.674 | 7,186.467 | 6,441.03 | 6,314.505 | 5,931.5 | 7,239.228 | 7,040.071 | 6,327.114 | 6,716.268 | 5,621.146 | 4,335.161 | 3,707.532 | 3,215.192 | 2,892.143 | 2,284.162 | 2,105.645 | 1,752.284 | 1,390.669 | 1,105.49 | 875.335 | 498.64 | 377.408 | 307.671 | 183.549 | 152.587 | 142.887 |
Gross Profit
| 4,379.726 | 4,184.251 | 5,038.016 | 4,949.999 | 4,913.366 | 4,757.28 | 4,255.941 | 3,332.299 | 2,693.352 | 2,440.314 | 3,380.48 | 2,983.166 | 1,466.605 | 1,453.862 | 1,329.317 | 1,111.327 | 897.817 | 733.126 | 509.702 | 515.202 | 674.346 | 675.619 | 263.677 | 198.424 | 210.333 | 174.362 | 131.07 | 126.671 |
Gross Profit Ratio
| 0.448 | 0.403 | 0.419 | 0.408 | 0.433 | 0.43 | 0.418 | 0.315 | 0.277 | 0.278 | 0.335 | 0.347 | 0.253 | 0.282 | 0.293 | 0.278 | 0.282 | 0.258 | 0.225 | 0.27 | 0.379 | 0.436 | 0.346 | 0.345 | 0.406 | 0.487 | 0.462 | 0.47 |
Reseach & Development Expenses
| 357.689 | 391.953 | 428.694 | 372.796 | 401.149 | 903.817 | 639.53 | 439.464 | 411.037 | 445.703 | 417.632 | 396.649 | 326.948 | 202.453 | 192.449 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 178.337 | 175.438 | 265.943 | 214.255 | 218.884 | 237.597 | 262.304 | 225.419 | 226.478 | 185.397 | 256.733 | 173.267 | 115.91 | 80.912 | 89.775 | 410.611 | 350.581 | 321.313 | 269.046 | 225.709 | 275.083 | 301.165 | 130.573 | 97.609 | 105.632 | 83.643 | 51.612 | 49.435 |
Selling & Marketing Expenses
| 1,281.418 | 2,368.357 | 2,406.085 | 2,497.905 | 2,522.308 | 2,889.13 | 2,513.609 | 1,598.83 | 1,288.975 | 1,170.703 | 1,318.27 | 1,254.484 | 377.233 | 281.892 | 281.943 | 232.278 | 188.497 | 113.895 | 82.969 | 82.429 | 62.727 | 93.467 | 42.012 | 36.783 | 26.209 | 21.452 | 20.462 | 10.172 |
SG&A
| 1,459.755 | 2,533.348 | 2,672.028 | 2,712.16 | 2,741.192 | 3,126.726 | 2,775.912 | 1,824.249 | 1,515.453 | 1,356.1 | 1,575.003 | 1,427.751 | 493.143 | 362.804 | 371.718 | 642.889 | 539.078 | 435.208 | 352.015 | 308.138 | 337.81 | 394.633 | 172.585 | 134.392 | 131.841 | 105.095 | 72.075 | 59.607 |
Other Expenses
| 1,840.948 | 1,169.507 | 775.635 | 769.172 | 579.959 | 596.317 | -9.157 | 98.019 | 178.236 | 154.224 | 157.157 | 101.169 | 46.116 | 52.466 | 19.882 | 7.857 | 0.431 | -3.094 | 14.703 | 2.399 | -9.078 | -19.782 | -1.267 | 3.812 | 2.193 | -1.425 | -0.824 | -6.062 |
Operating Expenses
| 3,658.392 | 4,094.808 | 3,876.356 | 3,854.129 | 3,722.3 | 4,626.86 | 3,842.361 | 2,693.405 | 2,375.135 | 2,263.654 | 2,532.938 | 2,239.245 | 1,114.013 | 812.284 | 843.613 | 670.27 | 559.182 | 454.283 | 363.262 | 316.237 | 345.712 | 404.109 | 176.823 | 137.368 | 135.452 | 108.029 | 74.404 | 62.422 |
Operating Income
| 721.334 | 89.443 | 1,103.766 | 1,153.423 | 1,361.092 | 2,650.231 | -102.98 | 248.884 | 11.961 | 60.196 | 642.248 | 562.899 | 283.927 | 567.157 | 433.012 | 342.807 | 240.745 | 202.105 | 109.991 | 173.9 | 305.267 | 251.859 | 73.218 | 56.64 | 61.692 | 60.681 | 55.145 | 59.357 |
Operating Income Ratio
| 0.074 | 0.009 | 0.092 | 0.095 | 0.12 | 0.239 | -0.01 | 0.024 | 0.001 | 0.007 | 0.064 | 0.065 | 0.049 | 0.11 | 0.095 | 0.086 | 0.076 | 0.071 | 0.049 | 0.091 | 0.172 | 0.162 | 0.096 | 0.098 | 0.119 | 0.17 | 0.194 | 0.22 |
Total Other Income Expenses Net
| -3.262 | -172.31 | -420.343 | -509.232 | -456.95 | -13.764 | -292.435 | 84.792 | 175.273 | 129.294 | 156.18 | 98.628 | 46.106 | 32.638 | -1.724 | -69.986 | -84.47 | -71.456 | -58.311 | -29.268 | -33.041 | -20.614 | -2.033 | 1.432 | -3.816 | -2.887 | -0.904 | -6.256 |
Income Before Tax
| 718.072 | -82.867 | 683.423 | 644.191 | 904.142 | 507.094 | -112.344 | 347.213 | 187.513 | 209.366 | 798.428 | 661.527 | 330.032 | 618.797 | 449.96 | 350.664 | 240.899 | 193.943 | 106.411 | 168.594 | 295.274 | 231.245 | 71.185 | 58.072 | 63.652 | 57.794 | 54.241 | 53.101 |
Income Before Tax Ratio
| 0.073 | -0.008 | 0.057 | 0.053 | 0.08 | 0.046 | -0.011 | 0.033 | 0.019 | 0.024 | 0.079 | 0.077 | 0.057 | 0.12 | 0.099 | 0.088 | 0.076 | 0.068 | 0.047 | 0.088 | 0.166 | 0.149 | 0.093 | 0.101 | 0.123 | 0.161 | 0.191 | 0.197 |
Income Tax Expense
| 126.76 | 14.148 | 192.003 | 133.56 | 180.975 | 183.828 | 124.627 | 115.647 | 125.66 | 83.066 | 246.458 | 154.005 | 60.98 | 103.347 | 75.606 | 71.96 | 40.214 | 51.114 | 24.985 | 49.917 | 76.485 | 57.162 | 18.559 | 8.999 | 8.566 | 7.648 | 6.214 | 0 |
Net Income
| 601.183 | -93.171 | 488.86 | 486.888 | 723.167 | 323.266 | -492.474 | 13.566 | -94.428 | 13.567 | 307.897 | 301.857 | 301.29 | 504.081 | 365.762 | 272.25 | 195.321 | 139.672 | 80.339 | 115.877 | 217.246 | 172.156 | 50.104 | 48.543 | 55.782 | 49.457 | 47.304 | 52.555 |
Net Income Ratio
| 0.061 | -0.009 | 0.041 | 0.04 | 0.064 | 0.029 | -0.048 | 0.001 | -0.01 | 0.002 | 0.03 | 0.035 | 0.052 | 0.098 | 0.08 | 0.068 | 0.061 | 0.049 | 0.036 | 0.061 | 0.122 | 0.111 | 0.066 | 0.084 | 0.108 | 0.138 | 0.167 | 0.195 |
EPS
| 0.52 | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 | 0.01 | -0.1 | 0.01 | 0.35 | 0.36 | 0.36 | 0.61 | 0.48 | 0.38 | 0.27 | 0.19 | 0.12 | 0.12 | 0.22 | 0.18 | 0.053 | 0.052 | 0.054 | 0.069 | 0.066 | 0.073 |
EPS Diluted
| 0.52 | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 | 0.01 | -0.1 | 0.01 | 0.35 | 0.36 | 0.36 | 0.61 | 0.48 | 0.38 | 0.27 | 0.19 | 0.12 | 0.12 | 0.22 | 0.18 | 0.053 | 0.052 | 0.054 | 0.069 | 0.066 | 0.073 |
EBITDA
| 1,952.405 | 1,180.283 | 2,006.475 | 1,941.734 | 2,199.227 | 1,920.141 | 1,020.274 | 1,292.639 | 1,070.227 | 985.603 | 1,433.119 | 1,141.521 | 726.383 | 950.124 | 743.269 | 639.134 | 515.615 | 433.319 | 303.518 | 327.37 | 424.776 | 348.635 | 146.314 | 111.912 | 94.574 | 87.917 | 56.666 | 64.25 |
EBITDA Ratio
| 0.199 | 0.114 | 0.167 | 0.16 | 0.194 | 0.173 | 0.1 | 0.122 | 0.11 | 0.112 | 0.142 | 0.133 | 0.125 | 0.184 | 0.164 | 0.16 | 0.162 | 0.153 | 0.134 | 0.172 | 0.239 | 0.225 | 0.192 | 0.194 | 0.183 | 0.246 | 0.2 | 0.238 |